Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Clinical trial NCT00486213 · TERMINATED

Trial details

NCT number: NCT00486213
Sponsor: National Cancer Centre, Singapore
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatologic Complications Palmar-plantar Erythrodysesthesia Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2007-06-01
Primary completion: 2014-08-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.